In accordance with the chemotaxis assay data, MβCD treatment enhanced the number of CD8+ T cells in tumor tissues of C57BL/6 mice treated with B3GALT4-knockdown 9464D cells (Fig. 7H). Here, B3GALT4 is linked to neoplasm.